Follow on Google News News By Tag * Biotech Breakout Trader * Biotech * Biotech Stocks * Small Cap Stocks * Breakout Biotech Stocks * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | BioTech Breakout Trader Rakes in 12,000% Plus in ReturnsMark Messier Turned $2,800 into over $280,000 in Just Under 3 years and is going to show traders exactly how he does it in his new BioTech Breakout Trader Program.
By: Brian T. With Mark's BioTech Breakout Trader strategies, you won't have to worry about timing the market or a company as he has mastered an exact formula that has allowed him to make over 12,000% in returns in the last two and half years of trading biotech small cap stocks. Some traders may say the key is to time when the FDA is about to approve a companies innovation and that will rocket their investment upward when approved. However, Mark believes this to be incorrect and is very risky. In fact, Mark Messier's BioTech Breakout Trader program teaches the exact opposite. His formula and strategies don't weigh in the FDA approvals. In fact, he only looks at the current facts and the statistics of these small companies which has proven successful for him in the past. The other upside to Mark's BioTech Breakout Trader is that this isn't some program that only caters to those who have $100,000 minimun investment. You can have as low as $500 or even $1,000 to start. In fact, Mark only started with just above $2,000 and in 2.5 years he has grown his account to over $280,000 by just trading BioTech Stocks with his proven formula. For more information on Mark Messier and his BioTech Breakout Trader program visit our review page where you will learn what's all included, exactly what you will get in the membership, and just how much of an investment it will be to gain access: http://forexlaunchcalendar.com/ # # # Our company releases public news on upcoming forex products that are about to be publicly released. Most press releases will include the name of the product, price it will be released at, and a brief description of the product. End
|
|